See also this year's filing and all EDGAR filings for this company.
PDF Report 0001023024_2016_ANI_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001023024, ANI Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 192,583,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 68,235,000 |
| 2 | PropertyPlantAndEquipmentNet | 7,131,000 |
| 3 | remainder_Assets | 17,316,000 |
| 4 | LiabilitiesCurrent | 11,756,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 113,427,000 |
| 7 | CostOfGoodsAndServicesSold | 12,932,734 |
| 8 | SellingGeneralAndAdministrativeExpense | 22,572,897 |
| 9 | ResearchAndDevelopmentExpense | 2,831,624 |
| 10 | remainder_Expenses | -5,484,981 |
| 11 | remainder_Revenues | 150,892,912 |
| 12 | remainder_NetIncome | -7,773,470 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 285,265,000 |
| 1 | Liabilities | 125,183,000 |
| 2 | Expenses | 32,852,274 |
| 3 | Revenues | 150,892,912 |
| 4 | StockholdersEquity | 160,082,000 |
| 5 | NetIncome | 110,267,168 |
| 6 | ComprehensiveNetIncome | 110,267,168 |
| 7 | BaseVar | 300,983,328 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.24 |
| 9 | EconomicCapitalRatio | 3.18 |
Edgar->Model Mapping
Feature Distribution
Change over Time
